Elite Pharmaceuticals Inc (ELTP)
0.5177
-0.06
(-9.98%)
USD |
OTCM |
Nov 14, 16:00
Elite Pharmaceuticals Gross Profit (Annual): 26.36M for March 31, 2024
Gross Profit (Annual) Chart
Historical Gross Profit (Annual) Data
Date | Value |
---|---|
March 31, 2024 | 26.36M |
March 31, 2023 | 16.59M |
March 31, 2022 | 14.80M |
March 31, 2021 | 11.87M |
March 31, 2020 | 7.979M |
March 31, 2019 | 2.868M |
March 31, 2018 | 3.948M |
March 31, 2017 | 3.739M |
March 31, 2016 | 8.014M |
Date | Value |
---|---|
March 31, 2015 | 2.002M |
March 31, 2014 | 1.365M |
March 31, 2013 | 1.088M |
March 31, 2012 | 1.410M |
March 31, 2011 | 1.591M |
March 31, 2010 | 1.038M |
March 31, 2009 | 0.8103M |
March 31, 2008 | 0.3886M |
March 31, 2007 | 0.3126M |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (Annual) Range, Past 5 Years
7.979M
Minimum
2020
26.36M
Maximum
2024
15.52M
Average
14.80M
Median
2022
Gross Profit (Annual) Benchmarks
Biomarin Pharmaceutical Inc | 1.904B |
BioCardia Inc | -- |
Zevra Therapeutics Inc | 24.52M |
Verrica Pharmaceuticals Inc | 4.378M |
Terns Pharmaceuticals Inc | -- |